XS
SM
MD
LG
XL
Regulatory News

Director/PDMR Shareholding

RNS Number : 0035H
Darktrace PLC
24 July 2023
 

24 July 2023

Darktrace plc

("Darktrace")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

Darktrace announces that it has been notified of the following PDMR transactions.

 

Nicole Eagan, Chief Strategy Officer and AI officer, has notified Darktrace that on 20 July 2023 she sold 585,425 ordinary shares in Darktrace. 

 

Contact:

Luk Janssens - Head of Investor Relations, Darktrace

[email protected]

 

Details of PDMR / person closely associated with them ("PCA")

Name

Nicole Eagan

Reason for the notification

Position / status

Chief Strategy Officer, AI Officer

Initial notification / amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Darktrace plc

LEI

213800PC5S5P9CSNFC89

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument

Identification code

Shares

 

 

Dark / GB00BNYK8G86

Nature of the transaction

Sale of ordinary shares

Currency

GBP - British Pound

Price(s) and volume(s)


Price(s)

Volume(s)


£3.93

585,425

  Aggregated

£3.93

585,425

Date of the transaction

20 July 2023

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALXLAEKDEFA